Torrisi R - Search Results

1

Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer.

Baglietto L, Torrisi R, Arena G, Tosetti F, Gonzaga AG, Pasquetti W, Robertson C, Decensi A. Baglietto L, et al. Among authors: torrisi r. Cancer Detect Prev. 2000;24(4):369-75. Cancer Detect Prev. 2000. PMID: 11059568 Clinical Trial.

2

Clinical Review on the Management of Breast Cancer Visceral Crisis.

Benvenuti C, Gaudio M, Jacobs F, Saltalamacchia G, De Sanctis R, Torrisi R, Santoro A, Zambelli A. Benvenuti C, et al. Among authors: torrisi r. Biomedicines. 2023 Apr 3;11(4):1083. doi: 10.3390/biomedicines11041083. Biomedicines. 2023. PMID: 37189701 Free PMC article. Review.

3

Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint.

Decensi A, Bruno S, Giaretti W, Torrisi R, Curotto A, Gatteschi B, Geido E, Polizzi A, Costantini M, Bruzzi P, et al. Decensi A, et al. Among authors: torrisi r. J Cell Biochem Suppl. 1992;16I:139-47. doi: 10.1002/jcb.240501327. J Cell Biochem Suppl. 1992. PMID: 1305678 Clinical Trial.

4

The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1.

Torrisi R, Pensa F, Fontana V, Costa A, Decensi A. Torrisi R, et al. Eur J Cancer. 1995;31A(3):420-1. doi: 10.1016/0959-8049(94)00524-9. Eur J Cancer. 1995. PMID: 7786612 No abstract available.

5

Pilot study of high dose fenretinide and vitamin A supplementation in bladder cancer.

Decensi A, Bruno S, Torrisi R, Parodi S, Polizzi A. Decensi A, et al. Among authors: torrisi r. Eur J Cancer. 1994;30A(12):1909-10. doi: 10.1016/0959-8049(94)00336-4. Eur J Cancer. 1994. PMID: 7880629 Clinical Trial. No abstract available.

6

DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPR.

Decensi A, Curotto A, Bruno S, Costantini M, Torrisi R, Gatteschi B, Cussotto M, Pizzorno R, Quattrini S, Repetto U, et al. Decensi A, et al. Among authors: torrisi r. Eur J Cancer Prev. 1994 Jul;3(4):377-9. doi: 10.1097/00008469-199407000-00017. Eur J Cancer Prev. 1994. PMID: 7950899 Clinical Trial. No abstract available.

7

Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.

Torrisi R, Parodi S, Fontana V, Rondanina G, Formelli F, Costa A, Boccardo F, Decensi A. Torrisi R, et al. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):507-10. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000302

8

Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints.

Decensi A, Formelli F, Torrisi R, Costa A. Decensi A, et al. Among authors: torrisi r. J Cell Biochem Suppl. 1993;17G:226-33. doi: 10.1002/jcb.240531142. J Cell Biochem Suppl. 1993. PMID: 8007703 Clinical Trial.

9

Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?

Decensi A, Torrisi R, Fontana V. Decensi A, et al. Among authors: torrisi r. Br J Cancer. 1994 Mar;69(3):617-9. doi: 10.1038/bjc.1994.115. Br J Cancer. 1994. PMID: 8123500 Free PMC article. Clinical Trial.

10

Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancer.

Decensi A, Torrisi R, Fontana V, Marroni P, Padovani P, Guarneri D, Minuto F, Boccardo F. Decensi A, et al. Among authors: torrisi r. Acta Endocrinol (Copenh). 1993 Oct;129(4):315-21. doi: 10.1530/acta.0.1290315. Acta Endocrinol (Copenh). 1993. PMID: 8237249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters